MMP2 and acute kidney injury: Employing the MMP‐2 reactive peptide PVGLIG enabled the polymer prodrug to swiftly release curcumin after arriving at the target tissue, enhancing the drug levels.[131] This enzyme‐triggered drug release strategy, while increasing the drug concentration in lesion tissues, can also reduce systemic toxicity, which is important for the treatment of AKI.